Skandinaviska Enskilda Banken (SEB)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,000
Closed -$680K 793
2023
Q4
$680K Hold
11,000
﹤0.01% 742
2023
Q3
$506K Sell
11,000
-2,200
-17% -$101K ﹤0.01% 769
2023
Q2
$759K Buy
+13,200
New +$759K 0.01% 736
2021
Q2
Sell
-36,800
Closed -$674K 1045
2021
Q1
$674K Hold
36,800
﹤0.01% 890
2020
Q4
$740K Sell
36,800
-23,600
-39% -$475K 0.01% 862
2020
Q3
$1.13M Hold
60,400
0.01% 708
2020
Q2
$1.36M Sell
60,400
-37,900
-39% -$851K 0.01% 660
2020
Q1
$1.46M Buy
98,300
+22,500
+30% +$334K 0.01% 563
2019
Q4
$1.46M Sell
75,800
-18,400
-20% -$355K 0.01% 637
2019
Q3
$1.87M Sell
94,200
-8,800
-9% -$175K 0.02% 563
2019
Q2
$2.17M Sell
103,000
-14,200
-12% -$300K 0.02% 487
2019
Q1
$2.39M Sell
117,200
-500
-0.4% -$10.2K 0.02% 425
2018
Q4
$2.34M Sell
117,700
-34,600
-23% -$688K 0.02% 433
2018
Q3
$2.93M Buy
152,300
+9,200
+6% +$177K 0.02% 407
2018
Q2
$2.18M Buy
143,100
+18,800
+15% +$287K 0.02% 411
2018
Q1
$2.33M Sell
124,300
-14,800
-11% -$278K 0.02% 367
2017
Q4
$2.68M Sell
139,100
-33,900
-20% -$652K 0.02% 381
2017
Q3
$3.09M Sell
173,000
-9,400
-5% -$168K 0.03% 376
2017
Q2
$3.26M Sell
182,400
-34,200
-16% -$611K 0.03% 367
2017
Q1
$3.14M Buy
216,600
+42,400
+24% +$615K 0.03% 364
2016
Q4
$3.21M Sell
174,200
-40,400
-19% -$744K 0.04% 304
2016
Q3
$4.07M Sell
214,600
-30,200
-12% -$573K 0.04% 296
2016
Q2
$3.95M Hold
244,800
0.04% 293
2016
Q1
$2.94M Sell
244,800
-39,200
-14% -$470K 0.03% 334
2015
Q4
$4.04M Buy
+284,000
New +$4.04M 0.05% 247